143 related articles for article (PubMed ID: 1706670)
1. Bioactivity of synthetic human cholecystokinin (CCK)-33 in vitro and in vivo.
Shinozaki H; Miyasaka K; Wakasugi H; Fujii N; Funakoshi A
Gastroenterol Jpn; 1991 Feb; 26(1):51-5. PubMed ID: 1706670
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of CR 1409 (cholecystokinin antagonist) on pancreatic exocrine secretion in rats].
Shiratori K; Watanabe S; Shimizu K; Moriyoshi Y; Chang JH; Takeuchi T
Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):70-6. PubMed ID: 2471850
[TBL] [Abstract][Full Text] [Related]
3. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
[TBL] [Abstract][Full Text] [Related]
4. Relative bioactivities of cholecystokinins-8 and -33 on rat pancreatic acini.
Liddle RA; Elashoff J; Reeve JR
Peptides; 1986; 7(5):723-7. PubMed ID: 2432584
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of CR-1409, a competitive inhibitor of cholecystokinin, on pancreatic exocrine secretion in the conscious rat.
Miyasaka K; Nakamura R; Funakoshi A; Kitani K
Tohoku J Exp Med; 1988 Jun; 155(2):165-72. PubMed ID: 3212779
[TBL] [Abstract][Full Text] [Related]
6. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
Louie DS; Liang JP; Owyang C
Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini].
Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851
[TBL] [Abstract][Full Text] [Related]
9. Effect of a novel cholecystokinin receptor antagonist, FK480, administered intraduodenally, on pancreatic secretion in rats.
Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S
Pancreas; 1995 Apr; 10(3):295-300. PubMed ID: 7542771
[TBL] [Abstract][Full Text] [Related]
10. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep.
Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R
Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo effect of proglumide on cholecystokinin-stimulated amylase release in mouse pancreatic acini.
Iwamoto Y; Nakamura R; Akanuma Y
Gastroenterol Jpn; 1984 Feb; 19(1):53-8. PubMed ID: 6202584
[TBL] [Abstract][Full Text] [Related]
12. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
[TBL] [Abstract][Full Text] [Related]
13. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
Menozzi D; Gardner JD; Jensen RT; Maton PN
Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic profile of TS-941, a new benzodiazepine derivative cholecystokinin-receptor antagonist, in in vitro isolated rat pancreatic acini.
Tashiro M; Hirohata Y; Kihara Y; Akiyama T; Otsuki M
Pancreas; 1999 Mar; 18(2):156-64. PubMed ID: 10090413
[TBL] [Abstract][Full Text] [Related]
15. Synthetic CCK8 analogs with antagonist activity on pancreatic receptors: in vivo study in the rat, compared to non-peptidic antagonists.
Nagain C; Galas MC; Lignon MF; Rodriguez M; Martinez J; Rozé C
Pancreas; 1991 May; 6(3):275-81. PubMed ID: 1713671
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory effect of CR-1409 on amylase secretion and intracellular Ca2+ mobilization in rat pancreatic acini in vitro.
Shinozaki H; Funakoshi A; Wakasugi H; Abe M
Jpn J Physiol; 1989; 39(4):585-93. PubMed ID: 2481056
[TBL] [Abstract][Full Text] [Related]
17. The effect of CR 1409, a potent CCK receptor antagonist, on basal and stimulated pancreatic secretion in rat.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1990; 5(1):60-4. PubMed ID: 2293712
[TBL] [Abstract][Full Text] [Related]
18. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S
Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254
[TBL] [Abstract][Full Text] [Related]
19. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
Iwamoto Y; Yamamoto R; Kuzuya T
Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574
[TBL] [Abstract][Full Text] [Related]
20. Effect of intrinsic CCK and CCK antagonist on pancreatic growth and pancreatic enzyme secretion in pancreaticobiliary diversion rats.
Bamba T; Ishizuka Y; Hosoda S
Dig Dis Sci; 1993 Apr; 38(4):653-9. PubMed ID: 7681747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]